• Something wrong with this record ?

The value of innovation in decision-making in health care in Central Eastern Europe - The Sixth International Conference, 2 June 2017, Belgrade, Serbia

T. Novakovic, AP. Martin, M. Parker, A. Ferrario, S. Vukovic, K. Łanda, J. Duba, D. Dankó, N. Kotsopoulos, B. Godman, J. Ristic, D. Stefanovic, D. Tesic,

. 2017 ; 17 (6) : 519-521. [pub] 20171009

Language English Country Great Britain

Document type Congress

Persistent link   https://www.medvik.cz/link/bmc18016319

The Pharmacoeconomics Section of the Pharmaceutical Association of Serbia organised a one day international conference on the value of innovation in decision-making in health care in Central and Eastern Europe. The focus of the conference was on reimbursement decisions for medicines using health technology assessment and the use of managed entry agreements (MEAs). The objectives of this conference were firstly to discuss the challenges and opportunities with the use of MEAs in Central and Eastern European countries; secondly the role of patient registries especially with outcome based schemes, and finally new approaches to improve accessibility to new medicines including better managing their entry.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18016319
003      
CZ-PrNML
005      
20180521094924.0
007      
ta
008      
180515s2017 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/14737167.2017.1385394 $2 doi
035    __
$a (PubMed)28946800
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Novakovic, Tanja $u a Pharmacoeconomics Section , Pharmaceutical Association of Serbia , Belgrade , Serbia.
245    14
$a The value of innovation in decision-making in health care in Central Eastern Europe - The Sixth International Conference, 2 June 2017, Belgrade, Serbia / $c T. Novakovic, AP. Martin, M. Parker, A. Ferrario, S. Vukovic, K. Łanda, J. Duba, D. Dankó, N. Kotsopoulos, B. Godman, J. Ristic, D. Stefanovic, D. Tesic,
520    9_
$a The Pharmacoeconomics Section of the Pharmaceutical Association of Serbia organised a one day international conference on the value of innovation in decision-making in health care in Central and Eastern Europe. The focus of the conference was on reimbursement decisions for medicines using health technology assessment and the use of managed entry agreements (MEAs). The objectives of this conference were firstly to discuss the challenges and opportunities with the use of MEAs in Central and Eastern European countries; secondly the role of patient registries especially with outcome based schemes, and finally new approaches to improve accessibility to new medicines including better managing their entry.
650    12
$a rozhodování $7 D003657
650    _2
$a poskytování zdravotní péče $x ekonomika $x metody $7 D003695
650    12
$a ekonomika farmaceutická $7 D017850
650    _2
$a východní Evropa $7 D005061
650    _2
$a lidé $7 D006801
650    _2
$a dávkové mechanismy $7 D012051
650    _2
$a hodnocení biomedicínských technologií $7 D013673
655    _2
$a kongresy $7 D016423
700    1_
$a Martin, Antony P $u b Liverpool Health Economics Centre , Liverpool University , Liverpool , UK.
700    1_
$a Parker, Mark $u c Zem Solutions d.o.o ., Belgrade , Serbia.
700    1_
$a Ferrario, Alessandra $u d Department of Population Medicine at Harvard Medical School and Harvard Pilgrim Health Care Institute , Harvard University , Boston , USA.
700    1_
$a Vukovic, Simo $u e Second Serbian Health Project , Ministry of Health , Belgrade , Serbia.
700    1_
$a Łanda, Krzysztof $u f National Center of Research & Development (NCBiR) of the Republic of Poland , Warsaw , Poland.
700    1_
$a Duba, Jaroslav $u g OAKS Consulting , Czech Republic.
700    1_
$a Dankó, Dávid $u h Institute of Management , Corvinus University of Budapest , Budapest , Hungary.
700    1_
$a Kotsopoulos, Nikolaos $u i Global Market Access Solutions , Mooresville , NC , USA. j School of Public Policy and Administration , University of Athens , Athens , Greece.
700    1_
$a Godman, Brian $u b Liverpool Health Economics Centre , Liverpool University , Liverpool , UK. k Division of Clinical Pharmacology, Karolinska Institute , Karolinska University Hospital Huddinge , Stockholm , Sweden. l Department of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences , University of Strathclyde , Glasgow , UK.
700    1_
$a Ristic, Jelena $u a Pharmacoeconomics Section , Pharmaceutical Association of Serbia , Belgrade , Serbia.
700    1_
$a Stefanovic, Danka $u a Pharmacoeconomics Section , Pharmaceutical Association of Serbia , Belgrade , Serbia.
700    1_
$a Tesic, Danka $u a Pharmacoeconomics Section , Pharmaceutical Association of Serbia , Belgrade , Serbia.
773    0_
$w MED00174435 $t Expert review of pharmacoeconomics & outcomes research $x 1744-8379 $g Roč. 17, č. 6 (2017), s. 519-521
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28946800 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180521095106 $b ABA008
999    __
$a ok $b bmc $g 1299943 $s 1013159
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 17 $c 6 $d 519-521 $e 20171009 $i 1744-8379 $m Expert review of pharmacoeconomics & outcomes research $n Expert rev. pharmacoecon. outcomes res. $x MED00174435
LZP    __
$a Pubmed-20180515

Find record

Citation metrics

Archiving options